Webinar banner
What can life science startups learn from The Titanic and Theranos?
While from different eras, The Titanic and Theranos are two now infamous examples of epic failure. But both are also reflective of the fact that it is seldom one thing—the iceberg or the CMS orders to cease operations—that caused the failure. Rather, it was a series of small decisions across multiple domains including the people, the market, the technology/product, and the company strategy that culminated in the disaster.

This interactive session, based on the book The Titanic Effect, will give insight into the factors that resulted in the sinking of both The Titanic and Theranos. We will then link these factors to life science startups, and discuss the steps life science founders and their supporters can take to avoid a similar collapse. Don’t let The Titanic Effect sink your startup!

Sep 17, 2019 07:30 PM in Eastern Time (US and Canada)

Webinar logo
* Required information


Dr. Todd Saxton
Associate Professor and Indiana Venture Faculty Fellow @IU Kelley School of Business
Dr. Todd Saxton is an award-winning professor of strategy and entrepreneurship. Todd has advised, helped launch, and invested in hundreds of startups spanning life sciences, software, sports, consumer products, and services. Todd serves on the board of multiple entrepreneurial ventures, including VisionTech Angel Partners, the largest angel investing group in Indiana, and Diagnotes, a venture- funded health IT firm he helped found. Todd co-founded the Indiana Chapter of SoPE in 2018, and took on the role of Vice President of Business Development for the Regenstrief Institute in 2019. He has published numerous book chapters and articles on corporate and startup strategies for success. Todd hails from New Jersey, and has lived in Virginia, the DC area, Pennsylvania, Wisconsin, and Bloomington IN, with stints in England and Australia. He currently lives in Indianapolis, IN.
Dr. M. Kim Saxton
Clinical Professor of Marketing @IU Kelley School of Business
Dr. M. Kim Saxton has over 30 years of marketing and market research experience, working with large corporations, startups and medium-sized businesses. Her research on market segmentation, branding, and venture ecosystems has received national recognition. Kim has won numerous school-wide teaching awards including the President’s Award for Teaching Excellence for all of the IU system. Currently, she is an Associate Editor on the Journal of Advertising Research. Kim is also an active angel investor and advisor to high-potential startups. She is a member of the advisory board for PERQ and The Startup Ladies. Kim grew up in Florida, went to school in Boston, and has lived in the DC area, Pennsylvania, and Wisconsin, currently residing in Indianapolis, IN.
Jeffrey Hausfeld MD, MBA, FACS
Chairman of the Board and Chief Medical Officer @BioFactura, Inc.
Jeffrey Hausfeld, M.D., M.B.A., F.A.C.S. recently orchestrated the oversubscribed Series A Financing of BioFactura and acted as the lead investor in this round. He serves as Chairman of the Board of BioFactura as well as Chief Medical Officer as the Company develops its biosimilar platforms and products. Dr. Hausfeld will continue to be instrumental in providing strategic perspectives and plans for the targeted deployment of resources, the designing of clinical trials, expanding business development within the Biotech and business communities, as well as monitoring the financial well-being and governance aspects for BioFactura. In addition to his activities at BioFactura, Dr. Hausfeld is presently developing assisted living facilities specializing in Alzheimer’s and dementia care. He serves as a consultant to several healthcare/life science startups in diagnostics, devices, biotech and Health IT.